MPS 1 Hurler Scheie

MPS 1 (Hurler-Scheie) / α-L-iduronidase deficiëntie

Naast MPS 1 (Hurler/Scheie) zijn er nog zes aandoeningen waarbij mucopolysacchariden zich in de lysosomen ophopen. Ze zijn allemaal vernoemd naar de eerste arts die de betreffende ziekte als eerste beschreef, maar hebben ook een nummer (MPS 2 t/m 7). Sommige zijn nog onder te verdelen in verschillende vormen, net als MPS 1 (Hurler/Scheie) Severe MPS I occurs in approximately 1 in 100,000 newborns. Attenuated MPS I is less common and occurs in about 1 in 500,000 newborns. How is the disease inherited? MPS I (Hurler-Scheie syndrome ) is caused by a recessive gene Hurler, Scheie and Hurler/Scheie Disease are forms of Mucopolysaccharidosis Type 1 and are also known respectively as MPS IH, IS and IHS. MPS I covers a wide spectrum of severity of symptoms. For convenience, children most severely affected are said to have Hurler disease

MPS I (Hurler, Hurler-Scheie, Scheie - MPS I - MPS Societ

Ziekte van Hurler/Scheie / Syndroom van Hurler-Scheie / MPS1-H/S Ziekte van Scheie / Syndroom van Scheie / MPS1-S. Meest gebruikte naam MPS 1, (Hurler) Informatie voor kinderen: stripalgemeen. Stripboek. Zijn er leden met deze ziekte? Er zijn momenteel geen leden met 'MPS 1-H (Hurler) Syndroom van Hurler' bij ons aangemeld. Datum laatst. MPS I: an overview Patients with mucopolysaccharidosis (MPS) I are at increased risk for severe morbidity and early mortality 1. MPS I is a progressive condition 2 that has been divided into 3 subtypes known as Hurler syndrome (MPS I-H), Hurler-Scheie syndrome (MPS I-H/S), and Scheie syndrome (MPS I-S). 3 All subtypes of MPS I are caused by a deficiency of the enzyme α-L-iduronidase, which is.

MPS I - Hurler, Scheie & Hurler/Scheie Disease - The Irish

The patients were categorised according to syndrome as follows: 143 Hurler, 41 Hurler-Scheie, and 12 Scheie. Prevalence. Figure 1 shows the three-year running average for MPS I births and for all births in England Wales 1981 to 2003. Of the 167 MPS I births 118, 38 and 11 were classified as Hurler, Hurler-Scheie and Scheie respectively MPS I includes Hurler, Hurler-Scheie and Scheie diseases. These diseases differ in severity of symptoms across a spectrum and are named after the doctors that identified them. Based on the presence of symptoms Hurler disease was first described by Dr Hurler in 1919, later in 1962 Dr Scheie identified a less severe form and referred to is as Scheie disease Mucopolysaccharidose type I (MPS I, Hurler/Hurler-Scheie/Scheie) MPS I is een stofwisselingsziekte die hoort tot de groep lysosomale stapelingsziekten, in het bijzonder de mucopolysaccharidosen. De expertisecentra voor deze aandoening zijn het Amsterdam UMC, locatie AMC en het Erasmus MC

Because it affects people in so many different ways, doctors used to separate MPS I into groups: Hurler, Hurler-Scheie, and Scheie syndromes. Now they talk about a range between two forms: Sever Hurler syndrome, also known as mucopolysaccharidosis Type IH (MPS-IH), Hurler's disease, and formerly gargoylism, is a genetic disorder that results in the buildup of large sugar molecules called glycosaminoglycans (AKA GAGs, or mucopolysaccharides) in lysosomes.The inability to break down these molecules results in a wide variety of symptoms caused by damage to several different organ systems. MPS I (mucopolysaccharidosis Type I or Hurler syndrome) is an inherited condition that involves the fourth chromosome. Symptoms of MPS I are thick lips, eye problems, and coarsening of facial features that become progressively worse. Treatment is focused on treating the signs and symptoms of the syndrome Although the term Hurler syndrome is still used, the term attenuated MPS I is now used in place of Hurler-Scheie and Scheie. NORD Video: Mucopolysaccharide storage disease type 1 (Hurler syndrome) Scroll back up to restore default view. Signs & Symptoms Mucopolysaccharidosis type I (MPS I) is a condition that affects many parts of the body. This disorder was once divided into three separate syndromes: Hurler syndrome (MPS I-H), Hurler-Scheie syndrome (MPS I-H/S), and Scheie syndrome (MPS I-S), listed from most to least severe

Hurler-Scheie syndrome Genetic and Rare Diseases

MPS I is een zeldzame erfelijke aandoening die ongeveer 1 op de 100.000 personen treft. De symptomen van MPS I kunnen per patiënt erg verschillen, en ook de ernst van de ziekte varieert van persoon tot persoon Mucopolysaccharidosis 1 (MPS1) (Hurler / Scheie syndrome) Contact details Molecular Genetics GOSH NHS Trust Level 6 York House 37 Queen Square London WC1N 3BH Telephone +44 (0) 20 7762 6888 Fax +44 (0) 20 7813 8196 Introduction MPS1 (MIM 252800) is an autosomal recessive lysosomal storage disorder, otherwis Globally, severe MPS I occurs in about 1 in every 100,000 births and is divided into three groups according to the type, severity, and the way the symptoms progress. Attenuated MPS I is less common, occurring in less than 1 in 500,000 births Having MPS I Each full sibling A person who shares the same mother or father. A brother or sister who shares both parents is called a full sibling. A brother or sister who only shares one parent is called a half sibling. (same mother and father) of a baby with MPS I has a 25% (1 in 4) chance of also having MPS I MPS 1, scheie, hurler-scheie en hurler syndroom has 39 members. een pagina voor ouders/verzorgers om ervaringen te delen en de mogelijkheid om contacten te legge

Mucopolysaccharidose I (MPS I) Erfelijkheid

  1. Hurler-Scheie syndroom (MPS I-H/S) MPS 1. Hoe wordt deze ziekte vastgesteld? MPS I wordt vermoed op grond van kenmerken die hierboven staan. De diagnose wordt gesteld met onderzoek van het bloed en de urine. Bij sommige mensen kan de diagnose bevestigd worden met genetisch onderzoek
  2. Mucopolysaccharidosis 1 (MPS1) (Hurler / Scheie syndrome) Contact details Regional Genetics Service Levels 4-6, Barclay House 37 Queen Square London, WC1N 3BH T +44 (0) 20 7762 6888 F +44 (0) 20 7813 8578 Samples required Hurler pati 5ml venous blood in plastic EDTA bottles (>1ml from neonates) Prenatal testing must be arrange
  3. The Orphan Disease Center: MPS I Pilot Grant Program presents a request for applications (RFA) to support research on the development of improved therapies for people with syndromes due to MPS I including Hurler, Hurler-Scheie and Scheie
  4. Start studying MPS I - Hurler/Scheie. Learn vocabulary, terms, and more with flashcards, games, and other study tools
  5. Incidence: Hurler syndrome, a Mucopolysaccharidosis type 1 (MPS I) condition, occurs in ~1/100,000 infants born.It is a panethnic condition, affecting individuals all over the world, however there is a higher proportion of infants born with Hurler syndrome in North America and Europe than in Latin America or the Asia Pacific region
  6. MPS I patients are commonly categorized into one of three clinical groups depending upon their cognitive functioning; Hurler, Hurler-Scheie, and Scheie. These three phenotypes can be further classified into two subgroups, Severe and Attenuated
  7. While affected individuals have traditionally been classified as having one of three MPS I syndromes (Hurler syndrome, Hurler-Scheie syndrome, or Scheie syndrome), no easily measurable biochemical differences have been identified and the clinical findings overlap; thus. Alice's MPS 1 Hurler journey. 277 likes

Abstract. Mucopolysaccharidosis I consists of three clinical entities with varying degree of clinical manifestations, all due to the same lysosomal enzyme deficiency, α-L-iduronidase.Hurler (MPS I-H) and Scheie (MPS I-S) syndromes represent phenotypes at the two ends of the clinical spectrum; the Hurler-Scheie syndrome (MPS I-H/S) represents a phenotype of intermediate clinical severity idosis (MPS) I H/S (Hurler-Scheie syndrome) and MPS I H (Hurler syndrome) is described. Physical examination, biochemical analysis, oph-thalmic examination and electroretinography were performed. The Hurler-Scheie patient (case 1) showed negative scotopic but normal photopic ERGs, which remained unchanged over 2 years MPS-1 Hurler/Scheie Related Tags of MPS-1 Hurler/Scheie MPS-1 Financial Support, MPS-1 Financial Assistance, MPS-1 Help, MPS-1 Financial Help Financial Assistance by Conditio MPS I is a rare condition that is seen in all populations; there are no known ethnic predilections. The incidence of severe MPS I is estimated to be approximately 1:100,000, and the attenuated MPS I is even rarer. [Moore: 2008 Hurler-Scheie syndrome is classified as a lysosomal storage disease.Patients with Hurler-Scheie syndrome lack the ability to break down GAGs in their lysosomes due a deficiency of the enzyme iduronidase.. All forms of mucopolysaccharidosis type I (MPS I) are a spectrum of the same disease. Hurler-Sheie is the subtype of MPS I with intermediate severity

Mucopolysaccharidosis - Wikipedi

MPS 1H/S symptoms, causes, diagnosis, and treatment information for MPS 1H/S (Mucopolysaccharidosis type I Hurler-Scheie syndrome) with alternative diagnoses, full-text book chapters, misdiagnosis, research treatments, prevention, and prognosis Tzetzi D(1), Hamilton R, Robinson PH, Dutton GN. Author information: (1)Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece. The configuration and progression of the ERG in two children with mucopolysaccharidosis (MPS) I H/S (Hurler-Scheie syndrome) and MPS I H (Hurler syndrome) is described Het MPS I ziektespectrum . Onderzoek en diagnose . Erfelijkheid . Verhalen van patiënten . Leven met MPS I . MPS I op het werk . MPS I aan je familie uitleggen . Ondersteuning voor ouders . Praten met je arts . Reizen . Behandelmogelijkheden . Locatie van behandelcentra . Informatiebronnen . MPSI. Search. Search. Search

MPS Disease - Symptoms, Treatment and Life Expectancy

(PDF) Mucopolysaccharidosis type I Hurler-Scheie syndrom

At the age of 5 years, corneal clouding was detected on a routine ophthalmological assessment. The patient was referred to Genetics and was found to have elevated GAG levels in his urine. Subsequent enzyme analysis revealed reduced fibroblast α-l-iduronidase enzyme activity, and the diagnosis of Hurler-Scheie syndrome (attenuated MPS I) was. MPS I and MPS II can lead to serious medical problems including early death. Symptoms may not present at birth, but frequently appear in early childhood and may include delayed development, enlarged internal organs, heart conditions, stunted growth, skeletal abnormalities, and joint problems People with severe MPS VII usually experience progressive storage of mucopolysaccharides in the brain that is primarily responsible for the slowing of intellectual development by 1 to 3 years of age. This is often followed by a gradual loss of skills until death however the pattern is very varied 1. MPS I Screening and Treatment Effects: Systematic Evidence Review 2. Population Health Outcomes of MPS I NBS: Decision Analysis 3. Public Health System Impact: Assessment of Feasibility and Readiness of the Public Health System to expand screening and follow up of MPS Mucopolysacharidosen (MPS) zijn progressieve ziekten die behoren tot de groep lysosomale stapelingsziekten.Mucopolysachariden ontstaan doordat een enzym, dat er voor moet zorgen dat glycosaminoglycanen afgebroken worden, ontbreekt of niet goed functioneert. Daardoor ontstaat een stapeling van deze stoffen, wat schadelijk is voor cellen, weefsels en organen

NeedyMeds is the best source of information on organizations offering programs that help with costs associated with specific diagnoses Phenotypes for disease #02622 (MPS-1HS (Hurler-Scheie syndrome (mucopolysaccharidosis (MPS-1HS))), OMIM:607015) Legend Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still Het MPS-Groepslabel maakt het mogelijk om voor een groep bedrijven (bijvoorbeeld een samenwerking van kwekers in een telersvereniging of coöperatie) één gezamenlijke status te tonen in de vorm van een label. Gecertificeerde handelaren. De lijst van gecertificeerde handelaren kunt u hier downloaden MPS I has an estimated incidence of 1 case per 100,000 live births, and the attenuated type represents about 20% of the total MPS I population. MPS I includes separate diseases on the basis of clinical presentation: Hurler Syndrome (severe), Hurler-Scheie syndrome (intermediate), and Scheie syndrome (mild) Guide to Understanding Mucopolysaccharidosis I (MPS I) Hurler, Hurler Scheie and Scheie DiseaseCreated OnJune 3, 2020Last Updated OnJune 3, 2020byMegan You are here: Main Rare Diseases Guide to Understanding Mucopolysaccharidosis [


Author information: (1)Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK. d.j.moore@bham.ac.uk BACKGROUND: Mucopolysaccharidosis type I (MPS I) is a rare lysosomal storage disease subdivided into three phenotypes of increasing severity: Scheie, Hurler-Scheie and Hurler Hurler-Scheie MPS I H/S Mild Scheie MPS I S. Liver secretes the therapeutic protein into the blood Reference ranges: Normal: 6.0-71.4 nmol/hr/mg MPS I (ERT-naïve): 0-1.0 nmol/hr/mg. Ch1 1e13 vg/kg Ch2 5e13 vg/kg SB-318-1502: Urine GAG Results 11 Subject 1 Study Day Subject 2 Subject 3 el* ne) Data cut-off date: 10 JAN 201 Guia para entender los syndromes de Hurler, Hurler-Scheie and Scheie. Source/Author: The MPS society Support Group IN SPANISH A booklet in pdf format on MPSI, discussing the cause, inheritance, prenatal diagnosis, clinical problems (divided by body system), general treatment and management and specific treatment of MPSI Samenvatting Epidemiologie De prevalentie van MPS I werd geschat op 1/100.000, waarbij syndroom van Hurler-Scheie 23% van de gevallen vertegenwoordigt en dus een prevalentie heeft van ongeveer 1/435.000

About Aldurazyme | Aldurazyme Healthcare Professionals

Phenotype distribution was 60.9% for Hurler, 23.0% for Hurler-Scheie, and 12.9% for Scheie (3.2% undetermined) syndromes. Median age at symptom onset for Hurler, Hurler-Scheie, and Scheie syndromes was 6 months, 1.5 years, and 5.3 years, respectively; median age at treatment initiation was 1.5 years, 8.0 years, and 16.9 years, respectively MPS I is a multisystem progressive disorder demonstrating wide phenotypic variability with three different MPSI subtypes described (Hurler, Hurler-Scheie, and Scheie). Hurler syndrome is considered the more severe end of the phenotypic spectrum with patients generally diagnosed before 18 months of age while Hurler-Scheie and Scheie syndromes are usually used to describe the milder phenotypes

Mucopolysacharidose I - Wikipedi

Hurler-Scheie syndrome is an intermediate form of mucopolysaccharidosis type I (MPS I) which is a rare autosomal recessive lysosomal storage disorder caused by mutations in the alpha-L-iduronidase gene, responsible for a deficiency or complete absence of enzyme alpha-L-iduronidase activity [1, 2].It results, therefore, in a progressive intracellular accumulation of non-metabolized. Mucopolysaccharidosen: MPS I: syndroom van Hurler (E76.01) syndroom van Hurler-Scheie (E76.02) syndroom van Scheie (E76.03) MPS II: syndroom van Hunter (E76.1 Hurler-Scheie Syndrome Clinical Trials, 18 Results, Page 1. A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme ® Treated Patients. Condition(s): Mucopolysaccharidosis I; Hurler's Syndrome; Hurler-Scheie Syndrome; Scheie's Syndrome Last Updated: May 5, 2014 Complete Mucopolysaccharidoses are rare with an overall estimated incidence of 1:25,000 5. Most are inherited as autosomal recessive traits, similar to most other enzyme deficiencies (MPS type II is the exception, inherited as an X-linked mutation) 5. Diagnosi

Arthritis | Basicmedical Key

Examples include 1-deoxyidronojirimycin and 1-deoxygalactonojirimycin, evaluated pre-clinically for MPS I Hurler-Scheie and MPS III, respectively . The goal of substrate reduction therapy is to inhibit production of the stored substrate [ 59 ] attenuated MPS I. Table 1.2 outlines the broad spectrum and disease course of MPS I. There can be overlap across the spectrum, such as Hurler-Scheie, which can make it difficult to distinguish the forms at the time of presentation. Table 1.2. MPS I Disease Spectrum and Progression of the Natural History SEVERE ATTENUATE Sep 13, 2015 - Hurler, Scheie and Hurler/Scheie Disease are forms of Mucopolysaccharidosis Type 1 and are also known respectively as MPS IH, IS and IHS. MPS I covers a wide spectrum of severity of symptoms. For COMPASSIONATE ALLOWANCE INFORMATION: MPS I - HURLER SYNDROME ALTERNATE NAMES. Hurler Syndrome type IH; Alpha-L-iduronate deficiency; Mucopolysaccharidosis type I; MPS I H; Lipochondrodystrophy; Pfaundler-Hurler syndrome; Hurler-Pfaundler syndrome; Attenuated MPS I; MPS I S; Hurler-Scheie Syndrome; MPS 1 H/S; Lysosomal Storage Disease - Mucopolysaccharidosis Type Reversing Hurler-Scheie Syndrome: Success Stories Part 1 The Raw Vegan Plant-Based Detoxification & Regeneration Workbook for Healing Patients. Volume 6: Central, Health: Amazon.n

Problemi diagnostico-differenziali tra sindrome di Scheie (MPS I S) e sindrome di Hurler/Scheie (MPS I H/S). Presentazione di un caso di probabile sindrome di Scheie. Minerva Pediatrica, 40(4), 247-251 Newborn Screening Act Sheet Mucopolysaccharidoses Type I: Decreased Alpha-L-Iduronidase ©2019 Mayo Foundation for Medical Education and Research MC4091-89rev1219 Differential Diagnosis: Hurler syndrome (MPS IH), Hurler-Scheie syndrome (MPS IH/S), and Scheie syndrome (MPS IS) Condition Description: Mucopolysaccharidoses type I (MPS I) is a lysosomal storage disorder (LSD) caused by a defect in. Grouped papules in Hurler-Scheie syndrome James A. Schiro, MD,a Susan B. Mallory, MD,a Laurie Demmer, MD,b S. Bruce Dowton, MD,b and Markham C. Luke, MD,a Phi) St. Louis, Missouri In a patient with Hurler-Scheie syndrome, a type of mucopolysacchafidosis (I H/S), an initial presentation was grouped papules on the extensor surfaces on the upper portions of the arms and legs

IDUAW : The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by the deficiency of any of the enzymes involved in the stepwise degradation of dermatan sulfate, heparan sulfate, keratan sulfate, or chondroitin sulfate, also known as glycosaminoglycans (GAG). Accumulation of GAG in lysosomes interferes with normal functioning of cells, tissues, and organs Our purpose is to test delivery of ERT to the spinal fluid via intrathecal injection in patients with MPS I. In this pilot study, we will use recombinant human α-L-iduronidase administered intrathecally once per month for four months to individuals with the Hurler-Scheie and Scheie forms of MPS I and spinal cord compression Reversing Hurler-Scheie Syndrome: As God Intended The Raw Vegan Plant-Based Detoxification & Regeneration Workbook for Healing Patients. Volume 1: Central, Health: Amazon.n - Hurler (-Scheie) disease or syndrome - E76.02 - Mucopolysaccharidosis - E76.3 - Hurler-Scheie syndrome - E76.02 - type - I - Hurler-Scheie syndrome - E76.02; Approximate Synonyms. The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code: Mucopolysaccharidosis, MPS- Die Bestimmung der Aktivität des Enzyms α-Iduronidase in Leukozyten dient zur Diagnose einer MPS I/HS (Morbus Hurler/Scheie). Methode: fluorimetrische Enzymbestimmung Benötigtes Material: 10 ml EDTA-Blu

Dental Treatment of Hurler Scheie Syndrome (MPS IH/IS) Patient M ucopolysaccharidoses (MPS) are rare seen hereditary metabolic diseases caused by genetic disorders in lysosomal enzyme production.[1] MPSs are classified into seven types (I, II, III, IV, VI, VII and IX) according to the enzyme affected. Mucopolysaccharidosis I is an autosoma MPS type II komt voor bij 1 op de 150.000 mensen en MPS type VI komt voor bij 1 op de 600.000 mensen. Er zijn verschillende soorten MPS en de symptomen verschillen per type en ernst. Sommige patiënten hebben als baby al ernstige klachten terwijl anderen pas op volwassenleeftijd klachten krijgen. De verschillende types zijn: •Type I, syndroom. Mucopolysaccharidosis Type I (MPS I) (Hurler, Hurler-Scheie and Scheie Syndromes) CAUSE Mucopolysaccharidosis type I (MPS I) is an inherited condition that affects many different parts of the body. It is a lysosomal storage disorder. When a lysosomal enzyme is missing or decreased significantly, the lysosome cannot break down certain substances The incidence of MPS I disease is estimated to be about 1 in 100,000 and it affects males and females equally. Inheritance Pattern. Since MPS I disease is an autosomal recessive disorder, the parents of a child with MPS I are unaffected, healthy carriers of the condition and have one normal gene and one abnormal gene MPS 1 includes Hurler syndrome, Scheie syndrome and Hurler-Scheie syndrome, each differing in their severity. MPS 1 typically begins six months after birth, affecting one out of every 500,000.

MPS I Registry. The MPS I Registry program, sponsored and administered by Sanofi Genzyme, is a worldwide database that has been tracking health-related information for people with MPS I since 2003, helping doctors and healthcare professionals to understand the disorder MPS-1HS: Hurler-Scheie syndrome: IDUA: IDUA: 1: 1: Gerard C.P. Schaafsma: Legend Powered by LOVD v.3.0 Build 23 LOVD software ©2004-2020 Leiden University Medical Center. MPS 1 - Mucopolysaccharidosis. En sällsynt och ärftlig lysosomal inlagringssjukdom.infoavd@sanofi.com / www.sanofi.se / 08-6345000 / GZSE.ALDU.16.09.0144 / p.. Using a combination of mutation analysis and mutation scanning in a study of 85 MPS I families (73 Hurler, 5 Hurler/Scheie, 7 Scheie), Beesley et al. (2001) identified both IDUA mutations in 81 (95%) families, one IDUA mutation in 3 (3.5%) families, and none in 1 (1.1%) family. The families were screened for 9 known mutations. W402X. Including pupils with MPS IV Morquio & MPS I Hurler and Hurler Scheie in Primary Schools. Post navigation. Including pupils with physical difficulties in Early Years. Including Pupils with Osteogenesis Imperfecta (Brittle Bones) You May Also Like. LTS Job Description

Het MPS ABC peloton wordt sinds 2015 aangevoerd door MPS A+. Dit zijn de koplopers op duurzaamheidsgebied. Per 1 januari 2016 nog een speler bij in het peloton: MPS-A Natural Protected, de EKO variant in het peloton. MPS ABC. MPS heeft vijf niveaus: A+ Natural Protected, A+, A, B, C waarvoor een certificaat te behalen is Apr 22, 2015 - This website contains a database of hereditary disorders with important ocular features. It is a point-of-service portal site, designed specifically for clinical ophthalmologists for quick reference during office hours. Each description of a medical condition is linked to another page containing more information written in plain English for patients

Eye in Metabolic DisordersMucopolysaccharidosis type I Hurler-Scheie syndrome: ACarbohydratesMPS I | Cha-MPSPPT - Mucopolysaccharides PowerPoint Presentation - ID:1158702Lysosomal Storage Disorders | Musculoskeletal KeyAbout MPS | Cha-MPS Austrian
  • Basisschool Nijmegen Oost.
  • De Willem van de Bergh.
  • Weerbericht voor madeira, portugal.
  • Winkels in de buurt van Weerterbergen.
  • Su casa woonwinkel.
  • Voetbalweetjes België.
  • Computer totaal los nummer.
  • Opkoper oude keukens.
  • Paw Patrol kleurplaat.
  • IJskappen groeien 2020.
  • Cartoon tekenen voor beginners.
  • Hond likt knuffel.
  • Proximale bicepspeesruptuur.
  • 470 ohm Resistor Color Code.
  • Vertalen zonder limiet.
  • Ouderwets snoep.
  • Wet BIG medicatie toedienen.
  • Kartelmes action.
  • Mr Felt movie.
  • Wollen hemd dames HEMA.
  • Etymologie pittoresk.
  • Hoe lang van te voren insmeren zonnebank.
  • Marjorie Eaton.
  • Aftelkalender verjaardag.
  • Pepper Dell.
  • Dogepaleis.
  • La Baraque Zevenhuizen agenda.
  • Bergen Suriname.
  • Whales land.
  • Auto Abonnement Volkswagen.
  • Polyester stof.
  • Stadswandeling Brabant.
  • Guipure kant.
  • Muziekwinkel.
  • Whales land.
  • Funda Haren.
  • Tekenen bevalling kat.
  • Koolhydraatarme producten Jumbo.
  • Eurotiercé uitslagen.
  • Tionne watkins net worth.
  • Papier mache snel drogen.